SEARCH
Aeras and CNBG Sign Agreement on Tuberculosis Vaccine R&D Agreement to jointly develop new tuberculosis vaccines positions China as a critical player in the TB vaccine field
> read more
MORE NEWS: 1 / 2 / 3 / 4 / 5 /


XIX International AIDS Conference

July 22 2012 - July 27 2012 | WASHINGTON, D.C.

 

Tuberculosis kills one in four people with HIV. To draw attention to this deadly co-infection and progress in developing effective vaccines to protect people with and without HIV, Aeras will participate in the 19th International AIDS Conference in Washington, D.C. July 22-27.

read more
Q&A: Dr. Barry Walker Joins Aeras to Direct TB Vaccine Pre-Clinical Development Why tuberculosis is a global problem and how to solve it

Dr. Barry Walker is an immunologist with over 20 years of research experience in mycobacterial infections. Born and raised in Australia, Dr. Walker studied at the University of Western Australia in Perth then moved to the UK for his postdoctoral work, where he first became involved in tuberculosis research. For the past 18 years, Dr. Walker served as Principal Scientist at the National Institute of Biological Standards and Control in London. In June 2012, Dr. Walker joins the staff of Aeras as the Senior Director of Pre-Clinical Development. We spoke with Dr. Walker about his personal experiences with TB, what fascinates him about the disease, and how drug-resistant forms of tuberculosis threaten the air we breathe. 

read more
 
  • Our portfolio of vaccine candidates view
  • 2010 Annual Reportdownload
  • Aeras May 2012 Newsletterdownload


We will announce the next Thaler Lecture soon.

View Lecture Archives

   site by Darby Communications